DA
A launchpad for healthtech and techbio startups transforming pharma R&D.
About
DayOne Accelerator is a Basel-based program launched in 2018 that focuses on supporting early-stage healthtech and techbio startups aiming to accelerate pharmaceutical research and development. It offers a three-month hybrid accelerator program, providing direct access to industry experts, tailored support, and connections with leading life science companies, research institutions, mentors, and investors. The program is equity-free and fee-free, designed for ventures developing solutions in areas like drug discovery, clinical development, clinical trials optimization, biomarkers, companion diagnostics, data layers for R&D, organ-on-chip systems, organoids, non-animal methods, lab automation, and AI tools for clinical trials. Beyond the accelerator, DayOne offers post-programme support through DayOne NEXT, which can include cash grants, tailored services, and office space.
Tags
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does DayOne Accelerator do?
DayOne Accelerator is a Basel-based program launched in 2018 that focuses on supporting early-stage healthtech and techbio startups aiming to accelerate pharmaceutical research and development. It offers a three-month hybrid accelerator program, providing direct access to industry experts, tailored support, and connections with leading life science companies, research institutions, mentors, and investors. The program is equity-free and fee-free, designed for ventures developing solutions in area…
Where is DayOne Accelerator headquartered?
DayOne Accelerator is headquartered in Basel, Switzerland.
When was DayOne Accelerator founded?
DayOne Accelerator was founded in 2018.
What industry does DayOne Accelerator operate in?
DayOne Accelerator operates in HealthTech, TechBio, Biotechnology, Pharmaceuticals, Artificial Intelligence, Drug Discovery.